Asset

OLEZARSEN SODIUM

Ionis Pharmaceuticals Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 218614NDAIONIS PHARMACEUTICALS INC

Marketed products (2)

  • TRYNGOLZA (AUTOINJECTOR)
  • TRYNGOLZA (AUTOINJECTOR)